ArticleCancers2024

CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer.

Akira Ueda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.